Pembrolizumab in Combination with Flutamide Treatment for Recurrence / Metastasis HNSCC

NCT06694350 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Pembrolizumab+Flutamide

Sponsor

Zhejiang Provincial People's Hospital